InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.55
(
1.20%
)
US TECH 100
17,100.00
(
2.07%
)
Dow Jones
38,503.69
(
0.69%
)
Brent Oil
87.45
(
-0.14%
)
Bitcoin
66,809.08
(
0.60%
)
Post# of 396422
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Robertscott

Send PM Follow Ignore
Followers 97
Posts 128742
Boards Moderated 1
Alias Born 07/24/2016

Robertscott

Member Level

Re: None

Wednesday, 05/31/2017 2:15:08 PM

Wednesday, May 31, 2017 2:15:08 PM

Post# of 396422

$NPHC must read news: CORAL SPRINGS, FL--(Marketwired - May 31, 2017) - Nutra Pharma Corporation ( OTCQB : NPHC ), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced a collaboration today with the University of Maryland Bioprocess Scale-Up Facility (BSF) to optimize manufacturing processes for the production of RPI-78M for the planned upcoming clinical trials in Pediatric Multiple Sclerosis
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up